EMA401, An Orally Administered Highly Selective Angiotensin II Type 2 Receptor Antagonist, as a Novel Treatment for Postherpetic Neuralgia: A Randomised, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial
Lancet 383:1637-1647, Rice, A.C.,et al, 2014
Influenza Vaccination and Cardiovascular Risk in Patients with Recent TIA and Stroke
Neurol 82:1905-1913, Lavallee, P.C.,et al, 2014
Antiepileptic Drugs for Neuropathic Pain and Fibromyalgia
JAMA 312:182-183, Moore, A.,et al, 2014
Disseminated Varicella Zoster Virus Encephalitis
Lancet 384:1698, Chai, W. & Gong-Ruey Ho, M., 2014
VZV Ischemic Optic Neuropathy and Subclinical Temporal Artery Infection without Rash
Neurol 80:220-222, Nagel, M.,et al, 2013
Varicella-Zoster Virus Acute Myelitis in a Patient with MS Treated with Natalizumab
Neurol 80:1812-1813, Yeung, J.,et al, 2013
Association between Guillain-Barr� Syndrome and Influenza a (H1N1) 2009 Monovalent Inactivated Vaccines in the USA: A Meta-Analysis
Lancet 381:1461-1468, Salmon, D.,et al, 2013
Multifocal VZV Vasculopathy with Temporal Artery Infection Mimics Giant Cell Arteritis
Neurol 80:2017-2021, Nagel, M.,et al, 2013
Herpes Zoster Ophthalmicus-Induced Oculomotor Nerve Palsy
J Optom 6:60-65, Harthan, J.S. & Borgman, C.J., 2013
Rectal Ulcer in a Patient with VZV Sacral Meningoradiculitis (Elsberg Syndrome)
Intern Med 51:651-654, Matsumoto, H.,et al, 2012
Neuro-Sweets Disease
Pract Neurol 12:126-130, Maxwel,G.,et al, 2012
Fatal Varicella-Zoster Virus Vasculopathy Associated with Adalimumab Therapy
Arch Neurol 69:1193-1196, Baek, W.,et al, 2012
Effect of Vaccines on Bacterial Meningitis Worldwide
Lancet 380:1703-1711,1623, McIntyre, P.,et al, 2012
Clinicopathologic Conference,Necrotizing Noninflammatory Myopathy Consistent with Exposure to Statins
NEJM 36:944-954, Case 7-2012, 2012
Neurologic Complications of Influenza A (H1N1)pdm09
Neurol 79:1474-1481, Khandaker,G.,et al, 2012
Multiple Sclerosis Rebound Following Herpes Zoster Infection and Suspension of Fingolimod
Neurol 79:2006-2007,1942, Gross, C.M.,et al, 2012
Severe Herpes Simplex Virus Type-I Infections after Dental Procedures
Med Oral Patol Oral Cir Bucal 16:e15-e18, El Hayderi, L.,et al, 2011
Primary Varicella Zoster Infection Associated With Fingolimod Treatment
Neurol 76:1023-1024, Uccelli,A.,et al, 2011
Zoster Sine Herpete: Virologic Verification by Detection of Anti-VZV IgG Antibody in CSF
Neurol 76:484-485, Blumenthal,D.T.,et al, 2011
Mechanisms of Fingolimods Efficacy and Adverse Effects in Multiple Sclerosis
Ann Neurol 69:759-777, Cohen, J.A. & Chun, J., 2011
Pediatric Neurological Complications of 2009 Pandemic Influenza A (H1N1)
Arch Neurol 68:455-462, Kedia, S.,et al, 2011
Bacterial Meningitis in the United States, 1998-2007
NEJM 364:2016-25, Thigpen, M.C.,et al, 2011
Varicella zoster virus vasculopathy Analysis of virus-infected arteries
Neurol 77:364-370, Nagel, M.A.,et al, 2011
Lumbar Puncture in Paediatric Stroke
Lancet 378:848, Neuteboom, R.F.,et al, 2011
Narcolepsy Onset is Seasonal and Increased following the 2009 H1N1 Pandemic in China
Ann Neurol 70:410-417,A5, Han, F.,et al, 2011
Yellow Fever Vaccination and Increased Relapse Rate in Travelers with Multiple Sclerosis
Arch Neurol 68:1267-1271, Farez, M.F. and Correale, J., 2011
Postvaccination Miller Fisher Syndrome
Arch Neurol 68:1325-1327, Shoamanesh, A.,et al, 2011
Polyneuritis Cranialis Caused by Varicella Zoster Virus in the Absence of Rash
Neurol 74:85-86, Murata,K.,et al, 2010
Herpes Zoster Ophthalmicus and the Risk of Stroke: A Population-Based Follow-up Study
Neurol 74:792-797, 788, Lin, H.-C.,et al, 2010
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
NEJM 362:402-415, 456, Cohen,J.A.,et al, 2010
A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
NEJM 362:416-426, 456, Giovannoni,G.,et al, 2010
Infectious and Non-Infectious Neurologic Complications in Heart Transplant Recipients
Medicine 89:166-175, Mu�oz,P., et al, 2010
Longitudinally Extensive Transverse Myelitis Following Vaccination With Nasal Attenuated Novel Influenza A (H1N1) Vaccine
Arch Neurol 67:1018-1020, Akkad,W., et al, 2010
Herpes Zoster Ophthalmicus-Related Oculomotor Palsy Accompanied by Hutchinson Sign
Neurol 74:e65, Reilly, G.S. & Shin, R.K., 2010
Challenge of the Unknown: A Systematic Review of Acute Encephalitis in Non-Outbreak Situations
Neurol 75:924-932, Granerod,J. et al, 2010
Acute Disseminated Encephalomyelitis Following Vacicnation Against Human Papilloma Virus
Neurol 72:2132-2133, Wildemann,B.,et al, 2009
Increased Risk of Stroke After a Herpes Zoster Attack
Stroke 40:3443-3448, Kang,J.,et al, 2009
Should I Have an H1N1 Flu Vaccination After Guillain-Barr�
BMJ 339:635, Price,L., 2009
DNA �-Amyloid1-42 Trimer Immunization for Alzheimer Disease in a Wild-Type Mouse Model
JAMA 302:1796-1802, Lambracht-Washington,D.,et al, 2009
Brown-S�quard Syndrome After Herpes Zoster
Neurol 72:670-671, Young-Barbee,C.,et al, 2009
Hepatitis B Vaccine and the Risk of CNS Inflammatory Demyelination in Childhood
Neurol 72:873-880,870, Mikaeloff,Y.,et al, 2009
Opportunistic Infections and Other Risks with Newer Multiple Sclerosis Therapies
Ann Neurol 65:367-377, Berger,J.R. &Houff,S., 2009
Viral Meningitis
BMJ 336:36-40, Logan,S.A. &MacMahon,E., 2008
The Varicella Zoster Virus Vasculopathies: Clinical, CSF, Imaging, and Virologic Features
Neurol 70:853-860, Nagel,M.A.,et al, 2008
Steroid and Antiviral Treatment for Bells Palsy
Lancet 371:1818-1820, Hato,N.,et al, 2008
Tick-Borne Encephalitis
Lancet 371:1861-1871, Lindquist,L. &Vapalahti,O., 2008
Long-Term Effects of A�42 Immunisation in Alzheimers Disease: Follow-Up of a Randomised, Placebo-Controlled Phase I Trial
Lancet 372:216-223,180, Holmes,C.,et al., 2008
Central Nervous System Involvement after Herpes Zoster Ophthalmicus
Acta Ophthalmol 86:806-809, Haargaard, B.,et al, 2008
Cryptococcosis and Idiopathic CD4 Lymphocytopenia
Medicine 86:78-92, Zonios,D.I.,et al, 2007
Epidemic Meningitis, Meningococcaemia, and Neisseria meningitidis
Lancet 369:2196-2210, Stephens,D.S.,et al, 2007